XML 35 R89.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed consolidating financial information Cash Flows (Details) (USD $)
In Thousands, unless otherwise specified
1 Months Ended 12 Months Ended
May 31, 2013
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Operating Activities        
Net income   $ 140,249 $ 105,528 $ 135,393
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]        
Depreciation and amortization   190,778 192,005 158,026
Loss on early extinguishment of debt   1,992 2,225 6,485
Gain on sale of land parcels   (4,824) (1,864) (46)
Loss (gain) on sale of real estate   121 (1,564) 0
Impairment of real estate   0 11,400 994
Impairment of land parcel   0 2,050 0
Amortization of loan fees and costs   9,936 9,832 9,300
Amortization of debt premiums/discounts   529 511 3,819
Amortization of acquired above and below market leases   (3,316) (3,200) (9,332)
Deferred rent   (27,935) (28,456) (26,797)
Stock compensation expense   15,552 14,160 11,755
Equity in (income) loss related to subsidiaries   0 0 0
Investment gains   (7,050) (15,018) (4,846)
Investment losses   1,480 2,637 1,795
Changes in operating assets and liabilities:        
Restricted cash   899 (261) (465)
Tenant receivables   (1,519) (981) (2,359)
Deferred leasing costs   (54,825) (45,099) (56,226)
Other assets   (6,298) (4,069) (22,359)
Intercompany receivables and payables   0 0 0
Accounts payable, accrued expenses, and tenant security deposits   56,958 65,697 41,823
Net cash provided by operating activities   312,727 305,533 246,960
Investing Activities        
Proceeds from sale of properties   153,968 36,179 20,078
Additions to properties   (593,389) (549,030) (430,038)
Purchase of properties   (122,069) (42,171) (305,030)
Change in restricted cash related to construction projects   7,655 (9,377) (2,183)
Distribution from unconsolidated real estate entity   0 22,250 0
Contributions to unconsolidated real estate entity   (17,987) (6,700) (5,256)
Investments in subsidiaries   0 0 0
Additions to investments   (36,078) (36,294) (27,999)
Proceeds from investments   16,525 27,043 16,849
Net cash used in investing activities   (591,375) (558,100) (733,579)
Financing Activities        
Borrowings from secured notes payable   28,489 17,810 0
Repayments of borrowings from secured notes payable   (36,219) (26,367) (66,849)
Proceeds from issuance of unsecured senior notes payable   498,561 544,650 0
Principal borrowings from unsecured senior line of credit   729,000 847,147 1,406,000
Repayments of borrowings from unsecured senior line of credit   (1,091,000) (651,147) (1,784,000)
Principal borrowings from unsecured senior bank term loans   0 0 1,350,000
Repayment of unsecured senior bank term loan   (250,000) (250,000) (500,000)
Repurchase of unsecured senior convertible notes   (384) (84,801) (221,439)
Redemption of Series C Cumulative Redeemable Preferred Stock   0 (129,638) 0
Proceeds from issuance of Series E Cumulative Redeemable Preferred Stock   0 124,868 0
Transfers to/from parent company   0 0 0
Change in restricted cash related to financings   2,546 (7,428) 7,311
Deferred financing costs paid   (19,928) (13,225) (27,316)
Proceeds from common stock offering 534,469 534,469 97,890 451,539
Proceeds from exercise of stock options   0 155 2,117
Dividends paid on common stock   (169,076) (126,498) (106,889)
Dividends paid on preferred stock   (25,885) (27,819) (28,357)
Contributions by redeemable noncontrolling interests   0 0 9
Distributions to redeemable noncontrolling interests   (1,191) (1,249) (1,263)
Redemption of redeemable noncontrolling interests   0 (450) 0
Contributions by noncontrolling interests   0 1,875 1,000
Distributions to noncontrolling interests   (1,812) (913) (2,707)
Net cash provided by financing activities   197,570 314,860 479,156
Effect of foreign exchange rate changes on cash and cash equivalents   (2,197) 139 (5,230)
Net (decrease) increase in cash and cash equivalents   (83,275) 62,432 (12,693)
Cash and cash equivalents at beginning of period   140,971 78,539 91,232
Cash and cash equivalents at end of period   57,696 140,971 78,539
Supplemental Disclosure of Cash Flow Information        
Cash paid during the period for interest, net of interest capitalized   59,857 52,561 52,324
Non-Cash Investing Activities        
Note receivable from sale of real estate   38,820 6,125 0
Write-off of fully amortized improvements   0 (17,730) 0
Change in accrued capital expenditures   (21,310) 46,087 3,492
Alexandria Real Estate Equities, Inc. (Issuer)
       
Operating Activities        
Net income   136,217 102,126 131,418
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]        
Depreciation and amortization   5,907 6,490 4,938
Loss on early extinguishment of debt   1,992 2,225 6,485
Gain on sale of land parcels   0 0 0
Loss (gain) on sale of real estate   0 0  
Impairment of real estate     6,400 0
Impairment of land parcel     0  
Amortization of loan fees and costs   6,914 9,204 6,915
Amortization of debt premiums/discounts   111 114 3,534
Amortization of acquired above and below market leases   0 0 0
Deferred rent   (82) (224) 100
Stock compensation expense   15,552 14,160 11,755
Equity in (income) loss related to subsidiaries   (220,158) (194,566) (202,829)
Investment gains   0 0 0
Investment losses   0 0 0
Changes in operating assets and liabilities:        
Restricted cash   (2) (12) 4
Tenant receivables   0 11 (12)
Deferred leasing costs   (37) (305) (699)
Other assets   (5,606) 1,329 2,550
Intercompany receivables and payables   3,021 (826) (1,418)
Accounts payable, accrued expenses, and tenant security deposits   (13,485) 6,172 6,274
Net cash provided by operating activities   (69,656) (47,702) (30,985)
Investing Activities        
Proceeds from sale of properties   10,796 0 0
Additions to properties   0 (1,313) (1,624)
Purchase of properties   0 0 0
Change in restricted cash related to construction projects   0 0 0
Distribution from unconsolidated real estate entity     0  
Contributions to unconsolidated real estate entity   0 0 0
Investments in subsidiaries   (236,218) (197,665) (548,884)
Additions to investments   0 0 0
Proceeds from investments   0 0 0
Net cash used in investing activities   (225,422) (198,978) (550,508)
Financing Activities        
Borrowings from secured notes payable   0 0  
Repayments of borrowings from secured notes payable   0 0 0
Proceeds from issuance of unsecured senior notes payable   498,561 544,650  
Principal borrowings from unsecured senior line of credit   729,000 847,147 1,406,000
Repayments of borrowings from unsecured senior line of credit   (1,091,000) (651,147) (1,784,000)
Principal borrowings from unsecured senior bank term loans       1,350,000
Repayment of unsecured senior bank term loan   (250,000) (250,000) (500,000)
Repurchase of unsecured senior convertible notes   (384) (84,801) (221,439)
Redemption of Series C Cumulative Redeemable Preferred Stock     (129,638)  
Proceeds from issuance of Series E Cumulative Redeemable Preferred Stock     124,868  
Transfers to/from parent company   0 0 0
Change in restricted cash related to financings   (1) 0 0
Deferred financing costs paid   (14,383) (10,180) (25,493)
Proceeds from common stock offering   534,469 97,890 451,539
Proceeds from exercise of stock options     155 2,117
Dividends paid on common stock   (169,076) (126,498) (106,889)
Dividends paid on preferred stock   (25,885) (27,819) (28,357)
Contributions by redeemable noncontrolling interests       0
Distributions to redeemable noncontrolling interests   0 0 0
Redemption of redeemable noncontrolling interests     12  
Contributions by noncontrolling interests     0 0
Distributions to noncontrolling interests   0 0 0
Net cash provided by financing activities   211,301 334,639 543,478
Effect of foreign exchange rate changes on cash and cash equivalents   0 0 0
Net (decrease) increase in cash and cash equivalents   (83,777) 87,959 (38,015)
Cash and cash equivalents at beginning of period   98,567 10,608 48,623
Cash and cash equivalents at end of period   14,790 98,567 10,608
Supplemental Disclosure of Cash Flow Information        
Cash paid during the period for interest, net of interest capitalized   37,073 39,298 30,292
Non-Cash Investing Activities        
Note receivable from sale of real estate   29,820 0  
Write-off of fully amortized improvements     0  
Change in accrued capital expenditures   0 (2,000) (987)
Alexandria Real Estate Equities, L.P. (Guarantor Subsidiary)
       
Operating Activities        
Net income   205,919 184,428 191,674
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]        
Depreciation and amortization   0 0 0
Loss on early extinguishment of debt   0 0 0
Gain on sale of land parcels   0 0 0
Loss (gain) on sale of real estate   0 0  
Impairment of real estate   0   0
Impairment of land parcel   0 0  
Amortization of loan fees and costs   0 0 0
Amortization of debt premiums/discounts   0 0 0
Amortization of acquired above and below market leases   0 0 0
Deferred rent   0 0 0
Stock compensation expense   0 0 0
Equity in (income) loss related to subsidiaries   (205,993) (183,139) (192,143)
Investment gains   (3) (1,510) (427)
Investment losses   78 221 883
Changes in operating assets and liabilities:        
Restricted cash   0 0 0
Tenant receivables   0 0 0
Deferred leasing costs   0 0 0
Other assets   0 0 0
Intercompany receivables and payables   0 0 0
Accounts payable, accrued expenses, and tenant security deposits   0 0 0
Net cash provided by operating activities   1 0 (13)
Investing Activities        
Proceeds from sale of properties   0 0 0
Additions to properties   0 0 0
Purchase of properties   0 0 0
Change in restricted cash related to construction projects   0 0 0
Distribution from unconsolidated real estate entity     0  
Contributions to unconsolidated real estate entity   0 0 0
Investments in subsidiaries   (276,022) (158,022) (477,482)
Additions to investments   0 (353) (2,451)
Proceeds from investments   1,018 2,600 3,471
Net cash used in investing activities   (275,004) (155,775) (476,462)
Financing Activities        
Borrowings from secured notes payable   0 0  
Repayments of borrowings from secured notes payable   0 0 0
Proceeds from issuance of unsecured senior notes payable   0 0  
Principal borrowings from unsecured senior line of credit   0 0 0
Repayments of borrowings from unsecured senior line of credit   0 0 0
Principal borrowings from unsecured senior bank term loans       0
Repayment of unsecured senior bank term loan   0 0 0
Repurchase of unsecured senior convertible notes   0 0 0
Redemption of Series C Cumulative Redeemable Preferred Stock     0  
Proceeds from issuance of Series E Cumulative Redeemable Preferred Stock     0  
Transfers to/from parent company   273,089 157,689 475,873
Change in restricted cash related to financings   0 0 0
Deferred financing costs paid   0 0 0
Proceeds from common stock offering   0 0 0
Proceeds from exercise of stock options     0 0
Dividends paid on common stock   0 0 0
Dividends paid on preferred stock   0 0 0
Contributions by redeemable noncontrolling interests       0
Distributions to redeemable noncontrolling interests   0 0 0
Redemption of redeemable noncontrolling interests     0  
Contributions by noncontrolling interests     0 0
Distributions to noncontrolling interests   0 0 0
Net cash provided by financing activities   273,089 157,689 475,873
Effect of foreign exchange rate changes on cash and cash equivalents   0 0 0
Net (decrease) increase in cash and cash equivalents   (1,914) 1,914 (602)
Cash and cash equivalents at beginning of period   1,914 0 602
Cash and cash equivalents at end of period   0 1,914 0
Supplemental Disclosure of Cash Flow Information        
Cash paid during the period for interest, net of interest capitalized   0 0 0
Non-Cash Investing Activities        
Note receivable from sale of real estate   0 0  
Write-off of fully amortized improvements     0  
Change in accrued capital expenditures   0 0 0
Combined Non- Guarantor Subsidiaries
       
Operating Activities        
Net income   228,331 200,317 211,066
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]        
Depreciation and amortization   184,871 185,515 153,088
Loss on early extinguishment of debt   0 0 0
Gain on sale of land parcels   (4,824) (1,864) (46)
Loss (gain) on sale of real estate   121 (1,564)  
Impairment of real estate     5,000 994
Impairment of land parcel     2,050  
Amortization of loan fees and costs   3,022 628 2,385
Amortization of debt premiums/discounts   418 397 285
Amortization of acquired above and below market leases   (3,316) (3,200) (9,332)
Deferred rent   (27,853) (28,232) (26,897)
Stock compensation expense   0 0 0
Equity in (income) loss related to subsidiaries   (4,067) (3,638) (3,793)
Investment gains   (7,047) (13,508) (4,419)
Investment losses   1,402 2,416 912
Changes in operating assets and liabilities:        
Restricted cash   901 (249) (469)
Tenant receivables   (1,519) (992) (2,347)
Deferred leasing costs   (54,788) (44,794) (55,527)
Other assets   (692) (5,398) (24,909)
Intercompany receivables and payables   (3,021) 826 1,418
Accounts payable, accrued expenses, and tenant security deposits   70,443 59,525 35,549
Net cash provided by operating activities   382,382 353,235 277,958
Investing Activities        
Proceeds from sale of properties   143,172 36,179 20,078
Additions to properties   (593,389) (547,717) (428,414)
Purchase of properties   (122,069) (42,171) (305,030)
Change in restricted cash related to construction projects   7,655 (9,377) (2,183)
Distribution from unconsolidated real estate entity     22,250  
Contributions to unconsolidated real estate entity   (17,987) (6,700) (5,256)
Investments in subsidiaries   (13,445) (1,179) (11,951)
Additions to investments   (36,078) (35,941) (25,548)
Proceeds from investments   15,507 24,443 13,378
Net cash used in investing activities   (616,634) (560,213) (744,926)
Financing Activities        
Borrowings from secured notes payable   28,489 17,810  
Repayments of borrowings from secured notes payable   (36,219) (26,367) (66,849)
Proceeds from issuance of unsecured senior notes payable   0 0  
Principal borrowings from unsecured senior line of credit   0 0 0
Repayments of borrowings from unsecured senior line of credit   0 0 0
Principal borrowings from unsecured senior bank term loans       0
Repayment of unsecured senior bank term loan   0 0 0
Repurchase of unsecured senior convertible notes   0 0 0
Redemption of Series C Cumulative Redeemable Preferred Stock     0  
Proceeds from issuance of Series E Cumulative Redeemable Preferred Stock     0  
Transfers to/from parent company   252,596 199,177 562,444
Change in restricted cash related to financings   2,547 (7,428) 7,311
Deferred financing costs paid   (5,545) (3,045) (1,823)
Proceeds from common stock offering   0 0 0
Proceeds from exercise of stock options     0 0
Dividends paid on common stock   0 0 0
Dividends paid on preferred stock   0 0 0
Contributions by redeemable noncontrolling interests       9
Distributions to redeemable noncontrolling interests   (1,191) (1,249) (1,263)
Redemption of redeemable noncontrolling interests     (462)  
Contributions by noncontrolling interests     1,875 1,000
Distributions to noncontrolling interests   (1,812) (913) (2,707)
Net cash provided by financing activities   238,865 179,398 498,122
Effect of foreign exchange rate changes on cash and cash equivalents   (2,197) 139 (5,230)
Net (decrease) increase in cash and cash equivalents   2,416 (27,441) 25,924
Cash and cash equivalents at beginning of period   40,490 67,931 42,007
Cash and cash equivalents at end of period   42,906 40,490 67,931
Supplemental Disclosure of Cash Flow Information        
Cash paid during the period for interest, net of interest capitalized   22,784 13,263 22,032
Non-Cash Investing Activities        
Note receivable from sale of real estate   9,000 6,125  
Write-off of fully amortized improvements     (17,730)  
Change in accrued capital expenditures   (21,310) 48,087 4,479
Eliminations
       
Operating Activities        
Net income   (430,218) (381,343) (398,765)
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]        
Depreciation and amortization   0 0 0
Loss on early extinguishment of debt   0 0 0
Gain on sale of land parcels   0 0 0
Loss (gain) on sale of real estate   0 0  
Impairment of real estate     0 0
Impairment of land parcel     0  
Amortization of loan fees and costs   0 0 0
Amortization of debt premiums/discounts   0 0 0
Amortization of acquired above and below market leases   0 0 0
Deferred rent   0 0 0
Stock compensation expense   0 0 0
Equity in (income) loss related to subsidiaries   430,218 381,343 398,765
Investment gains   0 0 0
Investment losses   0 0 0
Changes in operating assets and liabilities:        
Restricted cash   0 0 0
Tenant receivables   0 0 0
Deferred leasing costs   0 0 0
Other assets   0 0 0
Intercompany receivables and payables   0 0 0
Accounts payable, accrued expenses, and tenant security deposits   0 0 0
Net cash provided by operating activities   0 0 0
Investing Activities        
Proceeds from sale of properties   0 0 0
Additions to properties   0 0 0
Purchase of properties   0 0 0
Change in restricted cash related to construction projects   0 0 0
Distribution from unconsolidated real estate entity     0  
Contributions to unconsolidated real estate entity   0 0 0
Investments in subsidiaries   525,685 356,866 1,038,317
Additions to investments   0 0 0
Proceeds from investments   0 0 0
Net cash used in investing activities   525,685 356,866 1,038,317
Financing Activities        
Borrowings from secured notes payable   0 0  
Repayments of borrowings from secured notes payable   0 0 0
Proceeds from issuance of unsecured senior notes payable   0 0  
Principal borrowings from unsecured senior line of credit   0 0 0
Repayments of borrowings from unsecured senior line of credit   0 0 0
Principal borrowings from unsecured senior bank term loans       0
Repayment of unsecured senior bank term loan   0 0 0
Repurchase of unsecured senior convertible notes   0 0 0
Redemption of Series C Cumulative Redeemable Preferred Stock     0  
Proceeds from issuance of Series E Cumulative Redeemable Preferred Stock     0  
Transfers to/from parent company   (525,685) (356,866) (1,038,317)
Change in restricted cash related to financings   0 0 0
Deferred financing costs paid   0 0 0
Proceeds from common stock offering   0 0 0
Proceeds from exercise of stock options     0 0
Dividends paid on common stock   0 0 0
Dividends paid on preferred stock   0 0 0
Contributions by redeemable noncontrolling interests       0
Distributions to redeemable noncontrolling interests   0 0 0
Redemption of redeemable noncontrolling interests     0  
Contributions by noncontrolling interests     0 0
Distributions to noncontrolling interests   0 0 0
Net cash provided by financing activities   (525,685) (356,866) (1,038,317)
Effect of foreign exchange rate changes on cash and cash equivalents   0 0 0
Net (decrease) increase in cash and cash equivalents   0 0 0
Cash and cash equivalents at beginning of period   0 0 0
Cash and cash equivalents at end of period   0 0 0
Supplemental Disclosure of Cash Flow Information        
Cash paid during the period for interest, net of interest capitalized   0 0 0
Non-Cash Investing Activities        
Note receivable from sale of real estate   0 0  
Write-off of fully amortized improvements     0  
Change in accrued capital expenditures   $ 0 $ 0 $ 0